Flucytosine is a medication used in the management and treatment of systemic and severe candida and cryptococcus infections. It is in the antimetabolite, antifungal class of drugs. This activity outlines the indications, action, and contraindications for flucytosine as a valuable agent in treating and managing severe fungal infections. This activity will highlight the mechanism of action, adverse event profile, and other key factors pertinent to members of the healthcare team in the care of patients with candida and cryptococcus infections and related conditions.

**Objectives:**
- Identify the mechanism of action of flucytosine.
- Describe the potential adverse effects of flucytosine.
- Summarize the indications for using flucytosine.
- Outline some interprofessional team strategies for improving care coordination and communication to advance flucytosine and improve outcomes.